The Governor and the Ohio Department of Agriculture (ODA) have balanced the concerns of dairy farmers, distributors, and consumers in crafting an emergency rule that addresses both sides of a product labeling dispute over dairy growth hormone, or recombinant bovine somatotropin (rbST), part of the growing debate over food quality and commercial food production. Executive Order 2008-038, which allows “rbST-free” milk labels while at the same time questioning their relevance, follows a pivotal meeting of the state advisory committee in December that framed the debate around the real vs. unreal dangers of rbST, also known as rbGH or the Monsanto trade name Posilac. Labels on posilac-free products will read “This milk is from cows not supplemented with rbST,” or contain a “substantially equivalent claim.” Labels must also include the following or substantially equivalent claim: “The FDA has determined that no significant difference has been shown between milk derived from rbST-supplemented and nonsupplemented cows.” |